| Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and in vivo efficacy K Al Ayed, RD Ballantine, M Hoekstra, SJ Bann, CMJ Wesseling, ... Chemical Science 13 (12), 3563-3570, 2022 | 25 | 2022 |
| The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria SJ Bann, RD Ballantine, SA Cochrane RSC medicinal chemistry 12 (4), 538-551, 2021 | 19 | 2021 |
| A Chemical-Intervention Strategy To Circumvent Peptide Hydrolysis by d-Stereoselective Peptidases SJ Bann, RD Ballantine, CE McCallion, PY Qian, YX Li, SA Cochrane Journal of Medicinal Chemistry 62 (22), 10466-10472, 2019 | 13 | 2019 |
| Linearization of the brevicidine and laterocidine lipopeptides yields analogues that retain full antibacterial activity RD Ballantine, K Al Ayed, SJ Bann, M Hoekstra, NI Martin, SA Cochrane Journal of Medicinal Chemistry 66 (8), 6002-6009, 2023 | 9 | 2023 |
| Synthesis and structure–activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine RD Ballantine, K Al Ayed, SJ Bann, M Hoekstra, NI Martin, SA Cochrane RSC Medicinal Chemistry 13 (12), 1640-1643, 2022 | 8 | 2022 |
| Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase TW Craven, MD Nolan, J Bailey, S Olatunji, SJ Bann, K Bowen, ... ACS Chemical Biology 19 (5), 1125-1130, 2024 | 1 | 2024 |
| A novel approach for the synthesis of the cyclic lipopeptide globomycin SJ Bann, SA Cochrane RSC Medicinal Chemistry, 2024 | | 2024 |
| Purification of novel phospholipase A2 enzymes with anticancer activity from Pseudechis australis snake venom J Boncan, S Bann, S Cochrane, D Cobice, S McClean, A Jordan, ... EUVEN 1st International Congress, 2021 | | 2021 |
